Menarini Group and NewAmsterdam Pharma Company N.V. are collaborating on drug development, seeking marketing authorization in Europe through the EMA and EC process.

The entities involved

• European Medicines Agency →

  highest regulatory authority on medicines in the European Union

  • IGC Pharma, Inc. is preparing data for potential U.S. FDA review and seeking EMA support for its lead drug candidate.Mon 14:18
  • Both the FDA and the European Medicines Agency are evaluating NervGen's lead therapeutic candidate.Fri 23:04
• European Commission →

  executive branch of the European Union

  • The European Commission aims to strengthen homegrown AI capabilities while global advanced models face usage restrictions.Mon 17:49
  • The European Commission has initiated economic support measures for Armenia, including funding transfers, trade program development, and import restrictions.Mon 17:26
• Europe →

  terrestrial continent located in north-western Eurasia

  • The European Central Bank is forced to raise interest rates due to energy price shocks from the Iran war and an influx of Chinese exports.Mon 17:49
  • Iran controls the Strait of Hormuz access, which is critical for Gulf States.Mon 17:41

Related events

• Oncopeptides AB's drug received a positive opinion from the EMA, leading to the European Commission making a final decision for the EU market.Sep 17
• EMA adopted a positive opinion and the European Commission granted marketing authorization for the drug Hopledo.Aug 28
• Both the FDA and the European Medicines Agency govern drug approval processes.Aug 12
• Citigroup involved in global financial markets; India and Canada aiming to close CEPA trade pact; Biocon arm seeks EMA CHMP approval for drug.Sep 21
• The European Medicines Agency provided a positive opinion on a drug developed by Novartis.Sep 21